NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Efficacy of Different Dietary Pattern in Long-term Weight Management

Not Yet RecruitingNA

Sponsor: Guang Ning

Conditions: Obesity and Overweight, Dietary Intervention

Interventions: Individualized dietary intervention, Traditional energy-restricted balanced diet

Countries: China

This study is a nationwide multi-center, long-term randomized controlled clinical trial, aiming to evaluate the effects of individualized dietary pattern management programs compared to traditional energy-restricted diets in weight management.

Eligibility overview

Sex: ALL

Age: 20 Years to 59 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. Male or female, aged 20-59 years
2. Obesity defined by BMI≥28 kg/m²;
3. With willingness to undergo dietary intervention for weight loss.

Exclusion Criteria:

1. BMI≥40 kg/m²;
2. Suffering from gastrointestinal diseases that affect food digestion and absorption (such as functional bowel disorders, etc.), or having a known history of food allergies, or having a history of previous gastrointestinal surgery that affects dietary intervention;
3. Suffering from diseases that affect body weight or glucose and lipid metabolism (such as uncontrolled hyponatremia, thyroid dysfunction, secondary hypertension, type 1 diabetes, Cushing's syndrome, etc.);
4. Currently undergoing pharmacological treatment that affects body weight or glucose and lipid metabolism (such as thyroid medications, corticosteroids, antidiabetic drugs, lipid-lowering drugs, diuretics, etc.);
5. Having been diagnosed with clinical cardiovascular disease (coronary heart disease, stroke, heart failure, etc.) or malignancy;
6. Suffering from severe liver or kidney disease (alanine aminotransferase or serum creatinine levels exceeding 2 times the upper limit of normal);
7. Pregnant, breastfeeding, or women of childbearing potential who are not using contraception;
8. Any condition deemed by the investigator to affect study compliance;
9. Currently participating in another interventional study or having participated in another drug clinical trial within the past 3 months.

Locations (1)

Shanghai, Shanghai Municipality, China